163 related articles for article (PubMed ID: 36550397)
1. Health care professionals' perceptions about atrial fibrillation care in the Brazilian public primary care system: a mixed-methods study.
Paschoal E; Gooden TE; Olmos RD; Lotufo PA; Benseñor IM; Manaseki-Holland S; Lip GYH; Thomas GN; Jolly K; Lancashire E; Lane DA; Greenfield S; Goulart AC;
BMC Cardiovasc Disord; 2022 Dec; 22(1):559. PubMed ID: 36550397
[TBL] [Abstract][Full Text] [Related]
2. Screening for Atrial Fibrillation--A Cross-Sectional Survey of Healthcare Professionals in Primary Care.
Taggar JS; Coleman T; Lewis S; Jones M
PLoS One; 2016; 11(4):e0152086. PubMed ID: 27035567
[TBL] [Abstract][Full Text] [Related]
3. Identifying and understanding the care pathway of patients with atrial fibrillation in Brazil and the impact of the COVID-19 pandemic: A mixed-methods study.
Goulart AC; Varella AC; Gooden TE; Lip GYH; Jolly K; Thomas GN; Lotufo PA; Greenfield S; Olmos RD; Bensenor IM; Manaseki-Holland S;
PLoS One; 2023; 18(10):e0292463. PubMed ID: 37824516
[TBL] [Abstract][Full Text] [Related]
4. Healthcare provider and patient perspectives on access to and management of atrial fibrillation in the Northern Province, Sri Lanka: a rapid evaluation of barriers and facilitators to care.
Sheron VA; Shanmugathas S; Gooden TE; Guruparan M; Kumarendran B; Lip GYH; Manaseki-Holland S; Nirantharakumar K; Shribavan K; Subaschandren K; Haniffa R; Surenthirakumaran R; Thomas GN; Uruthirakumar P; Greenfield S; Lane DA; Beane A;
BMC Health Serv Res; 2022 Aug; 22(1):1078. PubMed ID: 35999563
[TBL] [Abstract][Full Text] [Related]
5. Decision-making around antithrombotics for stroke prevention in atrial fibrillation: the health professionals' views.
Wang Y; Bajorek B
Int J Clin Pharm; 2016 Aug; 38(4):985-95. PubMed ID: 27286973
[TBL] [Abstract][Full Text] [Related]
6. Healthcare professionals' perceptions on barriers and facilitators to DMARD use in rheumatoid arthritis.
Voshaar MJH; van den Bemt BJF; van de Laar MAFJ; van Dulmen AM; Vriezekolk JE
BMC Health Serv Res; 2022 Jan; 22(1):62. PubMed ID: 35022034
[TBL] [Abstract][Full Text] [Related]
7. Patients' experiences of atrial fibrillation and non-vitamin K antagonist oral anticoagulants (NOACs), and their educational needs: A qualitative study.
Clarkesmith DE; Lip GYH; Lane DA
Thromb Res; 2017 May; 153():19-27. PubMed ID: 28314139
[TBL] [Abstract][Full Text] [Related]
8. Barriers to warfarin use for stroke prevention in patients with atrial fibrillation in Hong Kong.
Lee VW; Tam CS; Yan BP; Man Yu C; Yin Lam Y
Clin Cardiol; 2013 Mar; 36(3):166-71. PubMed ID: 23151816
[TBL] [Abstract][Full Text] [Related]
9. Factors influencing primary care physicians' prescribing behavior of anticoagulant therapy for the management of patients with non-valvular atrial fibrillation in Singapore: a qualitative research study.
Chaterji S; Lian LG; Lee TY; Chua L; Wee SY; Yap SL; K DL; Tan NC
BMC Fam Pract; 2021 May; 22(1):101. PubMed ID: 34034648
[TBL] [Abstract][Full Text] [Related]
10. Stroke prevention strategies in patients with atrial fibrillation and heart valve abnormalities: perceptions of 'valvular' atrial fibrillation: results of the European Heart Rhythm Association Survey.
Potpara TS; Lip GY; Larsen TB; Madrid A; Dobreanu D; Jędrzejczyk-Patej E; Dagres N;
Europace; 2016 Oct; 18(10):1593-1598. PubMed ID: 27876696
[TBL] [Abstract][Full Text] [Related]
11. Persistence and outcomes of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with non-valvular atrial fibrillation.
Wu S; Xie S; Xu Y; Que D; Yau TO; Wang L; Huang Y
J Clin Nurs; 2019 May; 28(9-10):1839-1846. PubMed ID: 30667111
[TBL] [Abstract][Full Text] [Related]
12. Anticoagulation adherence and its associated factors in patients with atrial fibrillation: a cross-sectional study.
Chen PT; Wang TJ; Hsieh MH; Liu JC; Liu CY; Wang KY; Laio WC
BMJ Open; 2019 Sep; 9(9):e029974. PubMed ID: 31481562
[TBL] [Abstract][Full Text] [Related]
13. Patient Adherence to Novel Oral Anticoagulants (NOACs) for the Treatment of Atrial Fibrillation and Occurrence of Associated Bleeding Events: A Systematic Review and Meta-analysis.
Shehab A; Bhagavathula AS; Abebe TB; Abegaz TM; Elnour AA; Sabbour HM; Uzzafer M; Hersi A; Hamad AK
Curr Vasc Pharmacol; 2019; 17(4):341-349. PubMed ID: 29359674
[TBL] [Abstract][Full Text] [Related]
14. Consumer-led screening for atrial fibrillation using consumer-facing wearables, devices and apps: A survey of health care professionals by AF-SCREEN international collaboration.
Boriani G; Schnabel RB; Healey JS; Lopes RD; Verbiest-van Gurp N; Lobban T; Camm JA; Freedman B
Eur J Intern Med; 2020 Dec; 82():97-104. PubMed ID: 32933842
[TBL] [Abstract][Full Text] [Related]
15. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
Sterne JA; Bodalia PN; Bryden PA; Davies PA; López-López JA; Okoli GN; Thom HH; Caldwell DM; Dias S; Eaton D; Higgins JP; Hollingworth W; Salisbury C; Savović J; Sofat R; Stephens-Boal A; Welton NJ; Hingorani AD
Health Technol Assess; 2017 Mar; 21(9):1-386. PubMed ID: 28279251
[TBL] [Abstract][Full Text] [Related]
16. Patients' and clinicians' perceptions of oral anticoagulants in atrial fibrillation: a systematic narrative review and meta-analysis.
Osasu YM; Cooper R; Mitchell C
BMC Fam Pract; 2021 Dec; 22(1):254. PubMed ID: 34937557
[TBL] [Abstract][Full Text] [Related]
17. Understanding the barriers to using oral anticoagulants among long-term aspirin users with atrial fibrillation - a qualitative study.
Ng VWS; Siu CW; Chiu PKC; Kng CPL; Jamieson E; Wong ICK; Lam MPS
BMC Health Serv Res; 2020 Nov; 20(1):1084. PubMed ID: 33238989
[TBL] [Abstract][Full Text] [Related]
18. Arrhythmia Recurrence After Atrial Fibrillation Ablation: Impact of Warfarin vs. Non-Vitamin K Antagonist Oral Anticoagulants.
Wen S; Pislaru C; Monahan KH; Barnes SM; Hodge DO; Packer DL; Pislaru SV; Asirvatham SJ
Cardiovasc Drugs Ther; 2022 Oct; 36(5):891-901. PubMed ID: 34003404
[TBL] [Abstract][Full Text] [Related]
19. Impact of care coordination on oral anticoagulant therapy among patients with atrial fibrillation in routine clinical practice in Japan: a prospective, observational study.
Ono F; Akiyama S; Suzuki A; Ikeda Y; Takahashi A; Matsuoka H; Sasaki M; Okamura T; Yoshihara N;
BMC Cardiovasc Disord; 2019 Oct; 19(1):235. PubMed ID: 31651245
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of atrial fibrillation and stroke risk assessment based on telemedicine screening tools in a primary healthcare setting.
de Moraes ERFL; Cirenza C; Lopes RD; Carvalho AC; Guimaraes PO; Rodrigues AAE; de Paola AAV
Eur J Intern Med; 2019 Sep; 67():36-41. PubMed ID: 31320151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
